Vyome Holdings, Inc.
HIND
$2.16
$0.052.37%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/29/2026
-
Seeking Alpha - Healthcare
5/28/2026
-
GuruFocus
5/28/2026
-
Business Wire
5/20/2026
-
TipRanks Financial Blog
5/12/2026
-
The Cerbat Gem
5/12/2026
-
Business Wire
4/29/2026
-
TipRanks Financial Blog
4/22/2026
-
TipRanks Financial Blog
4/22/2026
-
Business Wire
4/6/2026
-
Business Wire
3/29/2026
-
Ticker Report
3/26/2026
-
SeekingAlpha.com: All News
3/26/2026
-
The Fly
3/26/2026
-
Business Wire
2/24/2026
-
Business Wire
2/18/2026
-
TipRanks Financial Blog
2/18/2026
-
The Fly
2/18/2026
-
Business Wire
2/11/2026
-
The Fly
2/11/2026
-
Business Wire
2/2/2026
-
The Fly
2/2/2026
-
Business Wire
1/27/2026
-
Business Wire
12/25/2025
-
Zolmax
12/22/2025
-
Business Wire
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, May 12, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Beginning of September (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
973-832-8147
Address
Harvard Square
One Mifflin Place - Suite 400
Cambridge, MA 02138
One Mifflin Place - Suite 400
Cambridge, MA 02138
Country
Year Founded
--
Business Description
Sector
Vyome Holdings, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States. It operates through...
more